Saccharomyces cerevisiae is an outstanding cellular model for metabolic studies in glycation. Due to its high glycolytic activity, it produces methylglyoxal, a highly reactive intracellular glycation agent, at a rate of approx. 0.1% of the glycolytic flux. We investigated methylglyoxal metabolism in Saccharomyces cerevisiae cells, using haploid null mutants. Growth studies showed that the most sensitive strains to 2-oxoaldehydes were the null mutants for GSH1 and GLO1, coding for glutathione synthase I and glyoxalase I respectively. The GRE3 null mutant, lacking aldose reductase activity, is as sensitive as the control strain. Kinetic modelling and computer simulation of this type of experiment were also performed, and we concluded that the most important parameters for controlling the intracellular concentration of methylglyoxal are the activity of glyoxalase I and the GSH concentration. Moreover, our model predicts an intracellular steady-state concentration of methylglyoxal of approx. 2 µM. Our results show that the glyoxalase pathway is the main detoxification pathway for 2-oxoaldehydes in yeast, and is likely to be the key enzymatic anti-glycation agent in these cells.
Glycation in living cells
Glycation, the non-enzymatic and irreversible modification of amino groups in biological molecules by carbonyl compounds, occurs in all living cells. This process involves a complex sequence of reactions, including intramolecular rearrangements, dehydration and oxididation/reduction reactions, leading to the formation of AGEs (advanced glycation end products). Major targets are low-turnover macromolecules such as nucleic acids and proteins [1] .
AGE formation in proteins is equivalent to a point mutation, and therefore it has profound implications for the biochemical functionalities of these macromolecules. Glycated proteins are less soluble and more resistant to enzymatic hydrolysis. Protein AGEs are recognized by several receptors and lead to cell activation responses in macrophages and lymphocytes [2] . Increased protein glycation is associated with retinopathy and nephropathy in diabetes mellitus [3] . AGEs are also found in the characteristic brain lesions in Alzheimer's disease, namely in extracellular β-amyloid deposits [4] . Understanding AGE metabolism is therefore essential in order to develop paliative and curative therapies for these increasingly important human diseases.
The metabolism of AGEs is poorly characterized. Some AGEs may be catabolized by specific enzymes, such as amadoriase [5] . Since amadoriase has been found in only a few organisms and appears to act only on certain AGEs, its importance in AGE catabolism appears to be very limited. Indeed, AGEs show an extreme chemical diversity, and it is highly unlikely that a single enzyme may be involved in their catabolism.
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Another route for decreasing AGE formation in living cells lies in decreasing the concentrations of glycation agents. Although glucose is the most abundant of these, it is also less reactive when compared with glyoxal and methylglyoxal, two physiological 2-oxoaldehydes. Glyoxal is formed mainly from lipid peroxidation and glyoxalate oxidation. Methylglyoxal is a non-enzymatic by-product of glycolysis, being formed as a result of the irreversible β-elimination reaction of the phosphate group of D-glyceraldehyde 3-phosphate and dihydroxyacetone phosphate [6] . Methylglyoxal is formed enzymatically from dihydroxyacetone phosphate in a reaction catalysed by methylglyoxal synthase in bacteria [7] .
The main catabolic pathways for methylglyoxal in eukaryotic cells appear to be the reaction catalysed by aldose reductase and the glyoxalase pathway. Aldose reductase catalyses the formation of acetol from methylglyoxal in yeast [8] . The glyoxalase pathway is composed of two enzymes, glyoxalase I and glyoxalase II, and catalyses the formation of D-lactate from methylglyoxal using glutathione as cofactor [9] .
We investigated methylglyoxal catabolism in Saccharomyces cerevisiae using single gene deletion mutants to probe the relative importance of different metabolic pathways. In vivo fluxes of methylglyoxal were determined during yeast cell growth in D-glucose, and the steady-state kinetics of glyoxalase I and glyoxalase II were characterized in situ. A kinetic model was built for the computer simulation and quantitative analysis of methylglyoxal catabolism through the glyoxalase pathway in S. cerevisiae.
Probing metabolic pathways in yeast
The availability of S. cerevisiae collections of single-gene deletion strains makes it possible to investigate the effects of these deletions on physiological aspects of this yeast. Methylglyoxal is toxic and cytostatic, so we investigated the effects of methylglyoxal on yeast haploid strains in which different genes were deleted. The reference strain (BY4741; Mat a; his3 1; leu2 0; met15 0; ura3 0) as well as the mutant strains are deposited in the Euroscarf collection. Considering the main enzymatic routes for methylglyoxal catabolism, we used aldose reductase mutants where the GRE3 gene was deleted. For studying the glyoxalase pathway, we used strains lacking the GLO1 and GLO2 genes, encoding the cytosolic proteins with glyoxalase I and glyoxalase II activities respectively. Glyoxalase II is also found in the mitochondria, coded by the GLO4 nuclear gene [10] . Under our growth conditions, S. cerevisiae does not develop functional mitochondria and this gene is not expressed. Moreover, we also used a strain with a decreased glutathione concentration, where the GSH1 gene was deleted. Since this gene codes for one of the two glutathione synthases expressed in yeast, these cells still produce some glutathione, but in much lower quantities.
Yeast cell growth was followed spectrophotometrically, in a continuous fashion, using a closed flow system recirculating the culture between a spectrophotometer flow cell and a culture vessel. Stirring in both the flow cuvette and the culture vessel is essential. Data were acquired with a Beckman DU-7400 diode array spectrophotometer monitoring cell population growth at 640 nm ( Figure 1) .
When comparing the effects of 1 mM methylglyoxal on the growth of yeast strains lacking GRE3 (aldose reductase) or GLO1 (glyoxalase I) with that of the reference strain (BY4741), it is clear that the one lacking aldose reductase activity was not sensitive to the methylglyoxal concentration used (Figure 1a) . The strain lacking GLO1, however, was much more sensitive to the presence of methylglyoxal, showing a decreased growth rate when compared with the other two strains (Figure 1a) .
Therefore aldose reductase does not appear to be important for methylglyoxal catabolism in S. cerevisiae, while the glyoxalase pathway does appear to be relevant. Surprisingly, GLO2-deficient strains are no more sensitive to methylglyoxal than the reference strain (Figure 1b) . This unexpected result hints at the importance of GSH concentration and of glyoxalase I activity for controlling the intracellular methylglyoxal concentration, and suggests that, in the presence of glyoxalase I and a high glutathione concentration (>5 mM in Saccharomyces cerevisiae), glyoxalase II plays a minor role in maintaining a low intracellular concentration of methylglyoxal. The GSH1 strain is the most sensitive to methylglyoxal.
In situ enzyme kinetics, metabolic fluxes in vivo and steady-state concentrations
We investigated glyoxalase I and glyoxalase II kinetics in situ in digitonin-permeabilized yeast cells (see Figure 2) . A detailed kinetic study, based on initial rate analysis and 
Figure 2 Glyoxalase pathway
Hemithioacetal (HTA) is formed in the non-enzymatic reaction between methylglyoxal and glutathione. Glyoxalase I (Glx1) kinetics were studied from time courses of S-d-lactoylglutathione (SDLGSH) formation followed at 240 nm, while glyoxalase II (GlxII) kinetics were studied from time courses of GSH formation. All kinetic experiments were performed at 30 • C in 0.1 M Mes/NaOH buffer, pH 6.5, in digitonin-permeabilized cells. Diode array spectrophotometers with in-cuvette stirring were used.
Modified from [12] . time course analysis using different steady-state kinetic models (reversible and irreversible reactions), was used [11] . Irreversible single-substrate models for glyoxalase I and II were found to be more suitable. The measured glyoxalase I/glyoxalase II activity ratio was approx. 20 [11] .
In vivo metabolic fluxes were determined during growth by measuring glucose and ethanol concentrations in the growth medium [12] . Methylglyoxal was measured with a specific HPLC-based assay [13] , while D-lactate was measured enzymatically. These determinations only compare the concentration difference as a function of time and therefore these flux measurements are not dependent on the absolute concentration values determined.
Data on enzyme activities and metabolic fluxes obtained in in situ experiments were subsequently integrated into a kinetic model of the glyoxalase system operating in yeast cells. This model included the reactions presented in Figure 2 , considering a steady input of methylglyoxal into the pathway.
We chose to simulate a scenario of 10 8 cells/ml growing in exponential phase in 100 mM D-glucose. This reference state was parameterized by the set of values indicated in the legend of Figure 3 . Computer simulations based on the set of differential equations derived from this kinetic model predict that the system attains a stable steady state where the concentrations of methylglyoxal, hemithioacetal and S-D-lactoylglutathione are 2.2 µM, 3.7 µM and 60.5 µM respectively. We then investigated the variation in this steady state due to a change of the activities of the two glyoxalases, total GSH concentration and input flux of methylglyoxal, as shown in Figure 3 . The results indicate that, for a given input flux, the concentration of the most reactive compound, methylglyoxal, is essentially determined by the concentration of GSH and the activity of glyoxalase I. Glyoxalase II, on the other hand, seems to have a negligible effect on the concentrations of methylglyoxal and hemithioacetal, a consequence of the irreversibility of the two glyoxalase reactions and the absence of any feedback interaction in the pathway.
However, one should notice that, in the reference state, the activity of glyoxalase II is only approx. 6 times the input flux of methylglyoxal. In Figures 3(B) and 3(D) it is shown that if the activity of glyoxalase II is decreased below 0.4 or if the input flux is increased above 6 times the values in the reference state, then the system is no longer able to regenerate GSH in a steady state. In this situation, there is accumulation of methylglyoxal after total GSH depletion. These results suggest that the glyoxalase system is operating close to saturation.
Living on the edge
The glyoxalase pathway is widespread in the biosphere, and an organism is yet to appear that lacks both glyoxalase I and glyoxalase II activity. In Saccharomyces cerevisiae it appears to be the main catabolic pathway for methylglyoxal, given our observations on the growth effects of methylglyoxal on different null mutant strains. The only strains that showed sensitivity to methylglyoxal were the ones lacking GSH1 or GLO1. Aldose reductase does not appear to be essential in this system, and the same was observed regarding GLO2. Enzyme activity determination in situ shows that glyoxalase II activity in a reference strain is about 20 times less than glyoxalase I activity.
Once the enzyme kinetic parameters were determined in situ, and the in vivo metabolic flux of methylglyoxal determined, it was possible to define a reference state for investigating the effects of several system parameters on steady-state concentrations (Figure 3) . A reference concentration of 5 mM GSH was chosen as a rather conservative estimate of intracellular GSH concentration in Saccharomyces cerevisiae [14] .
The most important parameters for controlling the intracellular concentration of methylglyoxal are the activity of glyoxalase I and the GSH concentration ( Figures 3A and  3C ). However, if the influx of methylglyoxal increases above glyoxalase II activity, the system will consume GSH and the methylglyoxal concentration will increase. Moreover, our model predicts an intracellular steady-state concentration of methylglyoxal of approx. 2 µM. Methylglyoxal will always be present, at a low concentration, and glycation will unavoidably occur in all living cells.
